# Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration

> **NCT02204683** · PHASE1 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 5 (actual)

## Conditions studied

- Neovascular Macular Degeneration

## Interventions

- **DRUG:** Aflibercept

## Key facts

- **NCT ID:** NCT02204683
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-05
- **Primary completion:** 2016-12-14
- **Final completion:** 2016-12-14
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2023-09-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02204683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02204683, "Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02204683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*